Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 71771-90-9, R(-)-denopamine, Kalgut, Ta 064, Ta-064, 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol
Molecular Formula
C18H23NO4
Molecular Weight
317.4  g/mol
InChI Key
VHSBBVZJABQOSG-INIZCTEOSA-N
FDA UNII
V5F60UPD8P

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(1R)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol
2.1.2 InChI
InChI=1S/C18H23NO4/c1-22-17-8-3-13(11-18(17)23-2)9-10-19-12-16(21)14-4-6-15(20)7-5-14/h3-8,11,16,19-21H,9-10,12H2,1-2H3/t16-/m0/s1
2.1.3 InChI Key
VHSBBVZJABQOSG-INIZCTEOSA-N
2.1.4 Canonical SMILES
COC1=C(C=C(C=C1)CCNCC(C2=CC=C(C=C2)O)O)OC
2.1.5 Isomeric SMILES
COC1=C(C=C(C=C1)CCNC[C@@H](C2=CC=C(C=C2)O)O)OC
2.2 Other Identifiers
2.2.1 UNII
V5F60UPD8P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (3,4-dimethoxyphenethylaminomethyl)-4-hydroxybenzyl Alcohol

2. 1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol

3. Ta 064

4. Ta-064

2.3.2 Depositor-Supplied Synonyms

1. 71771-90-9

2. R(-)-denopamine

3. Kalgut

4. Ta 064

5. Ta-064

6. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

7. V5f60upd8p

8. Chembl493682

9. Denopamina

10. Denopaminum

11. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxy-ethyl]phenol

12. Benzenemethanol, A-[[[2-(3,4-dimethoxyphenyl)ethyl]amino]methyl]-4-hydroxy-,(ar)-

13. Denopaminum [latin]

14. Kalgut (tn)

15. Denopamina [spanish]

16. Denopamine [inn:jan]

17. Unii-v5f60upd8p

18. R()-denopamine

19. Ncgc00094384-01

20. Denopamine [mi]

21. Denopamine (jan/inn)

22. Denopamine [inn]

23. Denopamine [jan]

24. Lopac-d-7815

25. Denopamine [mart.]

26. Denopamine [who-dd]

27. Dsstox_cid_25800

28. Dsstox_rid_81138

29. Dsstox_gsid_45800

30. Gtpl534

31. Schembl218640

32. Dtxsid8045800

33. Chebi:135359

34. Bcp17423

35. Zinc1552175

36. Tox21_111272

37. Bdbm50252956

38. (-)-(r)-1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol

39. Benzenemethanol, Alpha-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methyl)-4-hydroxy-, (r)-

40. Ncgc00015367-01

41. Cas-71771-90-9

42. Hy-119515

43. Cs-0068617

44. R(-)-denopamine, >=98% (hplc), Powder

45. D02614

46. Dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

47. (r)-4-(2-(3,4-dimethoxyphenethylamino)-1-hydroxyethyl)phenol

48. 4-[(1r)-2-[2-(3,4-

49. 4-[(1r)-2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl]phenol

50. (-)-(r)-.alpha.-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol

51. (-)-(r)-alpha-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol

2.4 Create Date
2005-12-16
3 Chemical and Physical Properties
Molecular Weight 317.4 g/mol
Molecular Formula C18H23NO4
XLogP31.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count8
Exact Mass317.16270821 g/mol
Monoisotopic Mass317.16270821 g/mol
Topological Polar Surface Area71 Ų
Heavy Atom Count23
Formal Charge0
Complexity320
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)


Adrenergic beta-Agonists

Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)